The WNBA hit a slam dunk with their COVID-19 safety protocols—they managed to run their entire 5 month season without a single COVID case. How? With rigorous policies that encircled 400 people into a single social bubble that required daily testing, meticulous entering or exiting protocols, and Oura Rings.
Early results from a large-scale COVID-19 study conducted at the University of California, San Francisco (UCSF), TemPredict, reveal that the Oura Ring's continuous temperature monitoring could make it an effective tool for fever monitoring and early illness detection.
A research team at the University of California, San Francisco (UCSF) has published early results from a large-scale COVID-19 study, TemPredict, revealing that the Oura Ring's temperature sensor could be an effective tool for fever monitoring and early illness detection.
"My doctor recommended a high dose of melatonin and low-dose beta-blockers. It was great to see the positive effects both interventions had on my Oura Ring data. My overnight heart rate stabilized and my sleep scores improved. That’s what he was trying to achieve.”
UCSF is testing whether physiological data collected by the Oura Ring, combined with responses to daily symptom surveys, can build an algorithm to identify patterns of, onset of, progression of, and recovery from, COVID-19.
With the NBA’s many high-profile players and personnel, accuracy regarding health information is business critical, and Oura responds to the timely need of bringing players and league staff peace of mind as they head to Orlando next month.
Oura has developed a pilot for a Health Risk Management Platform (HRM) platform designed for illness monitoring in workforce populations. HRM can support workforce safety and empower employers and employees alike to stay on top of their health.